Insider: Harmon Cyrus Director - Olema Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 727,770 | 117,028 | 844,798 |
| Value | $10,931,105.40 | $1,757,760.56 | $12,688,865.96 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/20/2026 | DDS | 10,000 | Direct | COM | $26.88 | $268,800.00 | 727,770 |
| 01/14/2026 | DDS | 3,489 | Direct | COM | $29.12 | $101,599.68 | 737,770 |
| 12/22/2025 | DDS | 2,881 | Direct | COM | $28.53 | $82,194.93 | 741,259 |
| 09/18/2025 | DDS | 10,000 | Direct | COM | $8.33 | $83,300.00 | 744,140 |
| 09/18/2025 | DDS | 3,086 | Indirect | COM | $8.32 | $25,675.52 | 117,028 |
| 09/16/2025 | DDS | 10,000 | Direct | COM | $8.04 | $80,400.00 | 754,140 |
| 09/16/2025 | DDS | 1,914 | Indirect | COM | $8.08 | $15,465.12 | 120,114 |
| 12/11/2024 | DDS | 7,958 | Direct | COM | $8.66 | $68,916.28 | 764,319 |
| 12/11/2024 | DDS | 179 | Direct | COM | $9.39 | $1,680.81 | 764,140 |
| 12/10/2024 | DDS | 8,256 | Direct | COM | $9.37 | $77,358.72 | 772,277 |
| 07/30/2024 | DDS | 934 | Direct | COM | $15.55 | $14,523.70 | 751,283 |
| 07/29/2024 | DDS | 4,066 | Direct | COM | $15.58 | $63,348.28 | 752,217 |
| 06/28/2024 | DDS | 20,000 | Direct | COM | $10.77 | $215,400.00 | 761,283 |
| 06/04/2024 | DDS | 5,000 | Direct | COM | $12.33 | $61,650.00 | 781,283 |
| 06/03/2024 | DDS | 5,000 | Direct | COM | $10.93 | $54,650.00 | 786,283 |
| 05/31/2024 | DDS | 15,000 | Direct | COM | $9.41 | $141,150.00 | 791,283 |
| 05/06/2024 | DDS | 5,000 | Direct | COM | $10.92 | $54,600.00 | 806,283 |
| 04/30/2024 | DDS | 15,000 | Direct | COM | $9.51 | $142,650.00 | 811,283 |
| 03/28/2024 | DDS | 20,000 | Direct | COM | $10.97 | $219,400.00 | 826,283 |
| 02/29/2024 | DDS | 24,900 | Direct | COM | $12.41 | $309,009.00 | 846,383 |
| 02/29/2024 | DDS | 100 | Direct | COM | $13.00 | $1,300.00 | 846,283 |
| 02/01/2024 | DDS | 5,000 | Direct | COM | $15.56 | $77,800.00 | 871,283 |
| 01/31/2024 | DDS | 25,000 | Direct | COM | $12.23 | $305,750.00 | 876,283 |
| 11/30/2023 | DDS | 25,000 | Direct | COM | $12.57 | $314,250.00 | 926,283 |
| 11/22/2023 | DDS | 3,989 | Direct | COM | $13.90 | $55,447.10 | 951,283 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research